Trademarkia Logo

Canada

C$
Trademark Search in Canada
BYVASDA

View On IC.GC.CA

BYVASDA
REGISTERED

on 31 May 2023

Last Applicant/ Owned by

INNOVENT BIOLOGICS (SUZHOU) CO. LTD.

No. 168, Dongping Street, Suzhou Industrial Park,Suzhou CityJiangsu Province

CN

Serial Number

2074622 filed on 25th Nov 2020

Registration Number

TMA1182508 registered on 31st May 2023

Registration expiry Date

25th Nov 2030

Correspondent Address

NEOMARK LTD.

7450 rue Saint-HubertMontréal

QUEBEC

CA

H2R2N3

BYVASDA

Trademark usage description

medicines for human purposes for the treatment of tumors, ophthalmology diseases, cardiovascular diseases, autoimmune diseases and disorders, immunolo Read More

Classification Information

Class [005]
Medicines for human purposes for the treatment of tumors, ophthalmology diseases, cardiovascular diseases, autoimmune diseases and disorders, immunologic deficiency syndromes, anemia, anorexia, arthritis, bulimia nervosa, gout, hyperlipidemia, hypothyroidism, insulin resistance, metabolic syndrome, muscular dystrophy, obesity, osteoarthritis, blood disorders, diabetes, growth and thyroid disorders, primary periodic paralysis, glucagonoma, disorders relating to sexual reproduction and fertility, respiratory system diseases, central nervous system [CNS] diseases, cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies, plexopathies, genetic diseases; medicines for human purposes that modulate the immune system; medicines for human purposes for regulating the immune system; medicines for human purposes being antivirals; biochemical medicines for the treatment of cancer; liquid medicines for the treatment of tumors, ophthalmology diseases, cardiovascular diseases, autoimmune diseases and disorders, immunologic deficiency syndromes, anemia, anorexia, arthritis, bulimia nervosa, gout, hyperlipidemia, hypothyroidism, insulin resistance, metabolic syndrome, muscular dystrophy, obesity, osteoarthritis, blood disorders, diabetes, growth and thyroid disorders, primary periodic paralysis, glucagonoma, disorders relating to sexual reproduction and fertility, respiratory system diseases, central nervous system [CNS] diseases, cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies, plexopathies, genetic diseases; liquid medicines for human purposes that modulate the immune system; liquid medicines for human purposes for regulating the immune system; liquid medicines for human purposes being antivirals; blood substitutes; pharmaceutical preparations for the treatment of gastrointestinal disorders; diagnostic chemical reagents for medical purposes; biological preparations for medical purposes for the treatment of osteoporosis; biological tissue cultures for veterinary purposes; drugs for medical purposes for the treatment of fever; diagnostic preparations for medical laboratory use; vaccines, namely human vaccines, veterinary vaccines; injectable medicine for treating tuberculosis

Classification kind code

11

Mark Details

Serial Number

2074622

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 13th Sept 2022		Agent Changed
Submitted for opposition 22
on 21st Mar 2022		Search Recorded
Submitted for opposition 20
on 21st Mar 2022		Examiner's First Report
Submitted for opposition 223
on 21st Mar 2022		Total Provisional Refusal
Submitted for opposition 256
on 1st Nov 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 31st Dec 2020		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 30th Dec 2020		Formalized
Submitted for opposition 1
on 30th Dec 2020		Created
Submitted for opposition 228
on 25th Nov 2020		International Registration
Submitted for opposition 30
on 25th Nov 2020		Filed